시판 후 약물감시를 위한 자료원별 약물 부작용 분석 방법 및 연구 동향

키워드

참고문헌 (64)

1. "Regulation and prequalification"[URL]
2. "MODULE 10: PHARMACOVIGILANCE"[URL]
3. "Guidelines for re-examination of new drugs, etc. (Complainant’s Guide)"[URL]
4. "Drug safety information-pharmacovigilance terminology"[URL]
5. "Analysis of drug side effects reporting trends in 2019. Press release" (2020)[URL]
6. "Trends in reporting safety information such as medicines in 2021"[URL]
7. Kim HH, "Big data analysis technology trends for predicting drug side effects", Korea Inform Proc Soc Rev, 24(5), pp.14~21 (2017)
8. "Pubmed"[URL]
9. "Medline"[URL]
10. Hersh WR, "Health informatics: practical guide", pp.68~ (2018), Lulu. com
11. "OMOP CDM"[URL]
12. "Sentinel common data model"[URL]
13. "Data"[URL]
14. "Reporting of adverse events-What is KAERS?"[URL]
15. "Korea Adverse Event Reporting System"[URL]
16. Asiamah M, "Spontaneous reporting of adverse drug reaction among health professionals in Ghana", Arch Public Health, 80(1), pp.33~ (2022)[DOI]
17. "Questions and answers on FDA’s adverse event reporting system (FAERS)"[URL]
18. "Introduction and application of health insurance review and assessment service claim data for health care service research"[URL]
19. "Finding and using health statistics"[URL]
20. "Research data assistance center (ResDAC)"[URL]
21. "Chronic Conition Data Warehouse"[URL]
22. "Twitter"[URL]
23. "Facebook"[URL]
24. Benetoli A, "How patients’ use of social media impacts their interactions with healthcare professionals", Patient Educ Couns, 101(3), pp.439~444 (2018)[DOI]
25. Laranjo L, "The influence of social networking sites on health behavior change : a systematic review and meta-analysis", J Am Med Inform Assoc, 22(1), pp.243~256 (2015)[DOI]
26. Zhang Y, "Adverse drug reaction detection on social media with deep linguistic features", J Biomed Inform, 106, pp.103437~ (2020)[DOI]
27. Park BJ, "Pharmacoepidemiology", pp.167~171 (2012), Seoul National University Publishing &Cultural Center
28. Park BJ, "Pharmacoepidemiology", pp.192~203 (2012), Seoul National University Publishing &Cultural Center
29. Park BJ, "Pharmacoepidemiology", pp.183~191 (2012), Seoul National University Publishing &Cultural Center
30. Jordan MI, "Machine learning : Trends, perspectives, and prospects", Science, 349(6245), pp.255~260 (2015)[DOI]
31. "Tensorflow"[URL]
32. "Keras"[URL]
33. "Pytorch"[URL]
34. "Scikit Learn"[URL]
35. "Colaboratory"[URL]
36. Wang N, "Safe medicine recommendation via star interactive enhanced-based transformer model", Comput Biol Med, 141, pp.105159~ (2022)[DOI]
37. "Data mining"[URL]
38. "Selenium"[URL]
39. "ANOVA"[URL]
40. "Fishers’ exact test"[URL]
41. "Student’s T-test"[URL]
42. "Likelihood-ratio test"[URL]
43. "Regression analysis"[URL]
44. "R"[URL]
45. "SPSS"[URL]
46. "SAS"[URL]
47. Wang F, "Estimating US earnings loss associated with COVID-19 based on human capital calculation", Int J Environ Res Public Health, 19(2), pp.1015~ (2022)[DOI]
48. 강정한, "코로나 위기가 학술 논문 생산에 미친 영향: KCI 등록 학술지 논문 분석", 한국사회학, 55(1), pp.179~199 (2021), 한국사회학회[DOI]
49. Radecki J, "The impacts of COVID-19 on the research enterprise : a landscape review", Ithaka S+R (2020)[DOI]
50. Bouzille G, "An automated detection system of drug-drug interactions from electronic patient records using big data analytics", Stud Health Technol Inform, 264, pp.45~49 (2019)[DOI]
51. Barnette DA, "Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam", Toxicol Lett, 338, pp.10~20 (2021)[DOI]
52. Wunnava S, "Adverse drug event detection from electronic health records using hierarchical recurrent neural networks with dual-level embedding", Drug Saf, 42(1), pp.113~122 (2019)[DOI]
53. Nishtala PS, "Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults", Pharmacoepidemiol Drug Saf, 29(12), pp.1689~1695 (2020)[DOI]
54. Ran J, "Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016", Int J Clin Pharm, 41(5), pp.1365~1372 (2019)[DOI]
55. Yang CC, "Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance", Artif Intell Med, 90, pp.42~52 (2018)[DOI]
56. Gawron AJ, "Risk of pancreatitis following treatment of irritable bowel syndrome with eluxadoline", Clin Gastroenterol Hepatol, 16(3), pp.378~384.e2 (2018)[DOI]
57. Geier DA, "The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995to 1999 in the United States", Int J Hyg Environ Health, 221(4), pp.677~683 (2018)[DOI]
58. Huang L, "Affiliations expand et al. Zero-inflated Poisson model based likelihood ratio test for drug safety signal detection", Stat Methods Med Res, 26(1), pp.471~488 (2017)[DOI]
59. Nam K, "Logistic regression likelihood ratio test analysis for detecting signals of adverse events in post-market safety surveillance", J Biopharm Stat, 27(6), pp.990~1008 (2017)[DOI]
60. Winterstein AG, "Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events", Am J Health Syst Pharm, 74(23), pp.1970~1984 (2017)[DOI]
61. Chung EK, "Causative agents of drug-induced pancreatitis : a nationwide assessment", Pancreas, 47(10), pp.1328~1336 (2018)[DOI]
62. "The need for national statistics production based on machine learning"[URL]
63. Kim YM, "Medical informatics research trend analysis : a text mining approach", Health Informatics J, 24(4), pp.432~452 (2018)[DOI]
64. "Health and medical data utilization guidelines"[URL]

관련 논문AI추천